⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
JNJ News
Johnson & Johnson
Impact Podcast with John Shegerian Announces All-Star Roster for New Season
businesswire.com
CROX
AMZN
MSFT
V
ZM
CBRE
HPQ
IBM
UBER
PEP
AVD
NU
TD
UPS
CRM
FTI
AMGN
HON
KHC
MAR
MORN
FDX
HTHT
LVS
SCL
SNA
WMT
XOM
GE
JNJ
KO
PG
TGT
DIS
MCD
SBUX
BA
CAT
DD
EMR
LMT
MMM
NEE
RTX
UNH
XRAY
ZTS
AMAT
ADSK
BIIB
BMY
CDNS
CHKP
CTAS
CTSH
DLTR
EA
EXPE
FAST
FIS
GILD
GOOG
HAS
HPE
INTC
INTU
ISRG
JD
LRCX
LIN
LULU
LYFT
MDLZ
MNST
MRNA
MU
NFLX
NVDA
ORCL
PAYX
PDD
PFE
PLTR
PPC
QCOM
REGN
ROST
SIRI
SNPS
SWKS
SYK
TCOM
TEAM
TER
TFX
TXN
ULTA
VRSK
VRTX
WDC
WEC
WST
WYNN
XEL
ZBRA
SAN
ACTG Announces Publication of LATITUDE Findings in the New England Journal of Medicine
globenewswire.com
VIV
JNJ
Firm-Record Nine Dean Omar Branham Shirley Attorneys Recognized for Plaintiff Consumer Law Excellence
businesswire.com
J
JNJ
Firm-Record Nine Dean Omar Branham Shirley Attorneys Recognized for Plaintiff Consumer Law Excellence
businesswire.com
J
JNJ
AAV for the Hereditary Retinal Diseases Competitive Landscape Report 2026: Comprehensive Insights About 75+ Companies and 80+ Drugs
globenewswire.com
NVS
JNJ
FDMT
Johnson & Johnson Expands U.S. Footprint with more than $1 Billion Investment in Next Generation Cell Therapy Manufacturing Facility in Pennsylvania
businesswire.com
JNJ
Johnson & Johnson Expands U.S. Footprint with more than $1 Billion Investment in Next Generation Cell Therapy Manufacturing Facility in Pennsylvania
businesswire.com
JNJ
Johnson & Johnson Expands U.S. Footprint with more than $1 Billion Investment in Next Generation Cell Therapy Manufacturing Facility in Pennsylvania
businesswire.com
JNJ
CraniUS Therapeutics Appoints Johnson & Johnson Senior Executive, Oray Boston Jr. to Board of Directors
prnewswire.com
JNJ
KDP
RYBREVANT FASPRO™ (amivantamab and hyaluronidase-lpuj) receives U.S. FDA Breakthrough Therapy Designation for patients with advanced head and neck cancer
prnewswire.com
JNJ